(1) SCOTTSDALE, AZ / ACCESSWIRE / March 17, 2021 / CBD Life Sciences, Inc. (OTC PINK:CBDL) ("CBD Life Science" or the "Company"), a manufacturer and distributor of organic cannabidiol based products, announces today its commitment to providing products with the highest standards for purity and potency in the CBD marketplace. In conjunction with this commitment, the Company has selected EVIO Labs ("EVIO"), for its best-in-class product CBD testing lab located in Berkeley, CA that provides ISO 17025 accredited CBD, Hemp testing services throughout the United States. CBD Life Sciences Inc. announced that it will now provide hemp oil and hemp derived CBD product testing for product manufacturers, retailers and consumers. CBD Life Sciences Inc. will now offer EVIO LABS ISO-17025 accredited CBD Safety Panel which includes the following tests: Cannabinoid Profile, Pesticides, Heavy Metals, Microbial Impurities Mycotoxins, and Moisture Content. In addition, CBD Life Sciences Inc. customers can also test the actual products they use for Residual Solvents like butane and propane, a full list of cannabinoids, and Vitamin E Acetate a substance linked to EVALI illnesses. President & CEO Lisa Nelson states "With the recent trend of consumers purchasing more hemp oil and hemp derived CBD products, we see this ISO-17025 accredited testing solution as an opportunity to provide a needed service for our customers." Lisa Nelson also states, "Third-party testing helps hemp CBD companies ensure the quality of their products, and it provides peace of mind for consumers." "Overall, this will bring in more business from customers, retailers, & big online distributors!"